Literature DB >> 21270213

Assessment of impact of peptide nucleic acid fluorescence in situ hybridization for rapid identification of coagulase-negative staphylococci in the absence of antimicrobial stewardship intervention.

Carol Holtzman1, Dana Whitney, Tamar Barlam, Nancy S Miller.   

Abstract

Peptide nucleic acid fluorescence in situ hybridization (PNA FISH) was instituted at Boston Medical Center for the rapid identification of coagulase-negative staphylococci (CoNS). Without active notification or antimicrobial stewardship intervention, a pre- and postimpact analysis showed no benefit of this assay with respect to the length of hospital stay or vancomycin use.

Mesh：

Substances：

Year:  2011        PMID： 21270213      PMCID： PMC3122789          DOI： 10.1128/JCM.02461-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  4 in total

1.  Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures.

Authors:  Graeme N Forrest; Sanjay Mehta; Elizabeth Weekes; Durry P Lincalis; Jennifer K Johnson; Richard A Venezia
Journal:  J Antimicrob Chemother       Date:  2006-04-24       Impact factor: 5.790

2.  Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs.

Authors:  G N Forrest; K Mankes; M A Jabra-Rizk; E Weekes; J K Johnson; D P Lincalis; R A Venezia
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

3.  Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy.

Authors:  Graeme N Forrest; Mary-Claire Roghmann; Latoya S Toombs; Jennifer K Johnson; Elizabeth Weekes; Durry P Lincalis; Richard A Venezia
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

4.  Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time.

Authors:  Tam Ly; Jyoti Gulia; Vasilios Pyrgos; Masashi Waga; Shmuel Shoham
Journal:  Ther Clin Risk Manag       Date:  2008-06       Impact factor: 2.423
  4 in total
  36 in total

1.  Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia.

Authors:  Abigail M Frye; Catherine A Baker; D Leif Rustvold; Kim A Heath; Jessica Hunt; James E Leggett; Margret Oethinger
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

Review 2.  Rapid molecular diagnostic tests in patients with bacteremia: evaluation of their impact on decision making and clinical outcomes.

Authors:  K Z Vardakas; F I Anifantaki; K K Trigkidis; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-02       Impact factor: 3.267

Review 3.  Better tests, better care: improved diagnostics for infectious diseases.

Authors:  Angela M Caliendo; David N Gilbert; Christine C Ginocchio; Kimberly E Hanson; Larissa May; Thomas C Quinn; Fred C Tenover; David Alland; Anne J Blaschke; Robert A Bonomo; Karen C Carroll; Mary Jane Ferraro; Lisa R Hirschhorn; W Patrick Joseph; Tobi Karchmer; Ann T MacIntyre; L Barth Reller; Audrey F Jackson
Journal:  Clin Infect Dis       Date:  2013-12       Impact factor: 9.079

4.  Clinical consequences of using PNA-FISH in Staphylococcal bacteraemia.

Authors:  R R Laub; J D Knudsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-10-16       Impact factor: 3.267

5.  Unanticipated Multiplex PCR-Based Identification of Polymicrobial Blood Culture Resulting in Earlier Isolation, Determination of Susceptibilities, and Optimization of Clinical Care.

Authors:  Tristan Timbrook; M Sean Boger; Lisa L Steed; John M Hurst
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

6.  Rapid testing using the Verigene Gram-negative blood culture nucleic acid test in combination with antimicrobial stewardship intervention against Gram-negative bacteremia.

Authors:  Jacqueline T Bork; Surbhi Leekha; Emily L Heil; LiCheng Zhao; Rilwan Badamas; J Kristie Johnson
Journal:  Antimicrob Agents Chemother       Date:  2014-12-29       Impact factor: 5.191

Review 7.  De-escalating Antibiotic Use in the Inpatient Setting: Strategies, Controversies, and Challenges.

Authors:  J Daniel Markley; Shaina Bernard; Gonzalo Bearman; Michael P Stevens
Journal:  Curr Infect Dis Rep       Date:  2017-04       Impact factor: 3.725

8.  Cumulative Effect of an Antimicrobial Stewardship and Rapid Diagnostic Testing Bundle on Early Streamlining of Antimicrobial Therapy in Gram-Negative Bloodstream Infections.

Authors:  P B Bookstaver; E B Nimmich; T J Smith; J A Justo; J Kohn; K L Hammer; C Troficanto; H A Albrecht; M N Al-Hasan
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

9.  Comparison of Pharmacist-Directed Management of Multiplex PCR Blood Culture Results with Conventional Microbiology Methods on Effective and Optimal Therapy within a Community Hospital.

Authors:  Allison M Porter; Christopher M Bland; Henry N Young; David R Allen; Sabrina R Croft; R Ellen Gayheart; Parks W Miller; Rachel J Musgrove; Emilee M Robertson; Geneen M Gibson
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

10.  Impact of QuickFISH in addition to antimicrobial stewardship on vancomycin use and resource utilization in cancer patients with coagulase-negative staphylococcal blood cultures.

Authors:  S K Seo; Z Gedrimaite; A Paskovaty; K Seier; S Morjaria; N Cohen; E Riedel; Y W Tang; N E Babady
Journal:  Clin Microbiol Infect       Date:  2018-03-13       Impact factor: 8.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.